Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Echinococcosis | Research

Viability predictive factors of the daughter vesicles in hepatic cystic echinococcosis

Authors: Aymen Trigui, Nahed Khmekhem, Sami Fendri, Rahma Daoud, Amira Akrout, Jihene Trabelsi, Rafik Mzali, Fatma Cheikhrouhou, Ali Ayadi, Chadli Dziri, Mohamed Ben Amar, Saleh Boujelbene

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Introduction

Management of cystic echinococcosis (CE) requires knowledge of certain aspects related to the survival of Echinococcus granulosus. The viability of daughter vesicles (DV) is a determining factor in guiding therapeutic indications, particularly for transiently active Cysts type CE3b.

Purpose

To determine the predictive factors of DV viability and its impact on the therapeutic management of CE3b type.

Materials and methods

This is a prospective pilot study with an analytical aim on patients with cystic echinococcosis of the liver type CE2 and CE3b, operated in the General Surgery Department of Habib-Bourguiba Academic Hospital, Sfax-Tunisia for 22 months from March 2018 until December 2019. The unit of the study is the DV. A parasitological study of the DV was done in the parasitology laboratory.

Results

During the study period, 27 (40.9%) of 66 operated CE Disease from 21 patients containing 248 DV were explored. The median viability of DV protoscoleces was 16.7%. In bivariate analysis, factors for viability of DV protoscoleces were: fever, acute cholangitis, hyperbilirubinemia, left liver location, rock water and bilious echinococcal fluid (EF), cyst size ≥ 43 mm, Intracystic pressure ≥ 35 mmHg, DV size ≥ 6.5 mm, volume, number of DV/cyst ≥ 5, and opaque wall (p < 0.05). Predictive factors for the Non-viability of DV were: CE3b type, purulent EF, gelatinous EF. In multivariate analysis, only CE2 type, cyst size ≥ 43 mm, number of DV/cyst ≥ 5 and DV size ≥ 6.5 mm were factors significantly associated with the viability of DV protoscoleces.

Conclusion

CE3b cysts without the criteria of viability of DV protoscoleces may become candidates for the ‘Wait-and-Watch’ procedure.
Literature
1.
go back to reference Zait H, Boulahbel M, Zait F, Achir I, Guerchani MT, Chaouche H. Hydatid fertility and protoscolex viability in humans: study of 78 hydatid samples collected between 2005 and 2012 and analyzed at the parasitology laboratory of the Mustapha University Hospital Center of Algiers. Med Sante Trop. 2013;23(2):235. Zait H, Boulahbel M, Zait F, Achir I, Guerchani MT, Chaouche H. Hydatid fertility and protoscolex viability in humans: study of 78 hydatid samples collected between 2005 and 2012 and analyzed at the parasitology laboratory of the Mustapha University Hospital Center of Algiers. Med Sante Trop. 2013;23(2):235.
2.
go back to reference Ould Ahmed Salem CB, Schneegans F, Chollet JY. Study of the lesional aspects of hydatid echinococcosis in humans in Mauritania: fertility, histology of hydatid cysts and viability of protoscolices. Bull Soc Pathol Exot. 2011;104(1):1–5.CrossRef Ould Ahmed Salem CB, Schneegans F, Chollet JY. Study of the lesional aspects of hydatid echinococcosis in humans in Mauritania: fertility, histology of hydatid cysts and viability of protoscolices. Bull Soc Pathol Exot. 2011;104(1):1–5.CrossRef
3.
go back to reference Brunetti E, Kern P, Vuitton DA. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop avr. 2010;114(1):1–16.CrossRef Brunetti E, Kern P, Vuitton DA. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop avr. 2010;114(1):1–16.CrossRef
4.
go back to reference Bygott JM, Chiodini PL. August. Praziquantel: neglected drug? Ineffective treatment? Or therapeutic choice in cystic hydatid disease? Acta Trop. 2009;111(2):95–101. Bygott JM, Chiodini PL. August. Praziquantel: neglected drug? Ineffective treatment? Or therapeutic choice in cystic hydatid disease? Acta Trop. 2009;111(2):95–101.
5.
go back to reference Hosch W, Stojkovic M, Jänisch T, Kauffmann GW, Junghanss T. The role of calcification for staging cystic echinococcosis (CE). Eur Radiol. 2007;17(10):2538–45.CrossRef Hosch W, Stojkovic M, Jänisch T, Kauffmann GW, Junghanss T. The role of calcification for staging cystic echinococcosis (CE). Eur Radiol. 2007;17(10):2538–45.CrossRef
6.
go back to reference Hosch W, Junghanss T, Stojkovic M, Brunetti E, Heye T, Kauffmann GW, et al. Metabolic viability assessment of cystic echinococcosis using high-field 1H MRS of cyst contents. NMR Biomed. 2008;21(7):734–54.CrossRef Hosch W, Junghanss T, Stojkovic M, Brunetti E, Heye T, Kauffmann GW, et al. Metabolic viability assessment of cystic echinococcosis using high-field 1H MRS of cyst contents. NMR Biomed. 2008;21(7):734–54.CrossRef
7.
go back to reference Arif SH, Shams-Ul-Bari null, Wani NA, Zargar SA, Wani MA, Tabassum R. and al. Albendazole as an adjuvant to the standard surgical management of hydatid cyst liver. Int J Surg. 2008;6(6):448–51. Arif SH, Shams-Ul-Bari null, Wani NA, Zargar SA, Wani MA, Tabassum R. and al. Albendazole as an adjuvant to the standard surgical management of hydatid cyst liver. Int J Surg. 2008;6(6):448–51.
8.
go back to reference N DD, U K. Medical treatment of pulmonary hydatid disease: for which child? Parasitol Int. 2005;54(2):135–8.CrossRef N DD, U K. Medical treatment of pulmonary hydatid disease: for which child? Parasitol Int. 2005;54(2):135–8.CrossRef
9.
go back to reference WHO Informal Working Group. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop. 2003;85(2):253–61.CrossRef WHO Informal Working Group. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop. 2003;85(2):253–61.CrossRef
10.
go back to reference Tsimoyiannis EC, Siakas P, Glantzounis G, Tsimoyiannis JC, Karayianni M, Gossios KJ. Intracystic pressure and viability in hydatid disease of the liver. Int Surg. 2000;85(3):234–6. Tsimoyiannis EC, Siakas P, Glantzounis G, Tsimoyiannis JC, Karayianni M, Gossios KJ. Intracystic pressure and viability in hydatid disease of the liver. Int Surg. 2000;85(3):234–6.
11.
go back to reference Dueger EL, Gilman RH. Prevalence, intensity, and fertility of ovine cystic echinococcosis in the central Peruvian Andes. Trans Royal Soc Trop Med Hygiene. 2001;95(4):379–83.CrossRef Dueger EL, Gilman RH. Prevalence, intensity, and fertility of ovine cystic echinococcosis in the central Peruvian Andes. Trans Royal Soc Trop Med Hygiene. 2001;95(4):379–83.CrossRef
12.
go back to reference Manterola C, Vial M, Melo A, Oberg C, Fonseca F. Viability and fertility of human hepatic hydatid cysts. World J Surg. 2006;30(2):227–32.CrossRef Manterola C, Vial M, Melo A, Oberg C, Fonseca F. Viability and fertility of human hepatic hydatid cysts. World J Surg. 2006;30(2):227–32.CrossRef
13.
go back to reference Gurri J. Vitality and evolutivity of hydatid scolices in vivo and in vitro. An Fac Med Univ Repub Montev Urug. 1963;48:372–81.PubMed Gurri J. Vitality and evolutivity of hydatid scolices in vivo and in vitro. An Fac Med Univ Repub Montev Urug. 1963;48:372–81.PubMed
14.
go back to reference El Saftawy EA, Abd-Elaal AA, Badawi MA, Abdelraouf AM, Shoeib EY, Mohsen A. Viability of hepatic hydatid cysts in relation to their parasitological, microbiological and radiological features in patients treated by different protocols. J Egypt Soc Parasitol. 2021;51(2):313–22.CrossRef El Saftawy EA, Abd-Elaal AA, Badawi MA, Abdelraouf AM, Shoeib EY, Mohsen A. Viability of hepatic hydatid cysts in relation to their parasitological, microbiological and radiological features in patients treated by different protocols. J Egypt Soc Parasitol. 2021;51(2):313–22.CrossRef
15.
go back to reference Gharbi HA, Hassine W, Brauner MW, Dupuch K. Ultrasound examination of the hydatic liver. Radiol. 1981;139(2):459–63.CrossRef Gharbi HA, Hassine W, Brauner MW, Dupuch K. Ultrasound examination of the hydatic liver. Radiol. 1981;139(2):459–63.CrossRef
16.
go back to reference Menezes da Silva A. Hydatid cyst of the liver-criteria for the selection of appropriate treatment. Acta Trop. 2003;85(2):237–42.CrossRef Menezes da Silva A. Hydatid cyst of the liver-criteria for the selection of appropriate treatment. Acta Trop. 2003;85(2):237–42.CrossRef
17.
go back to reference Dziri C, Haouet K, Fingerhut A. Treatment of hydatid cyst of the liver: where is the evidence? World J Surg. 2004;28(8):731–6.CrossRef Dziri C, Haouet K, Fingerhut A. Treatment of hydatid cyst of the liver: where is the evidence? World J Surg. 2004;28(8):731–6.CrossRef
18.
go back to reference Elissondo MC, Ceballos L, Alvarez L, Sánchez Bruni S, Lanusse C, Denegri G. Flubendazole and ivermectin in vitro combination therapy produces a marked effect on echinococcus granulosus protoscoleces and metacestodes. Parasitol Res. 2009;105(3):835–42.CrossRef Elissondo MC, Ceballos L, Alvarez L, Sánchez Bruni S, Lanusse C, Denegri G. Flubendazole and ivermectin in vitro combination therapy produces a marked effect on echinococcus granulosus protoscoleces and metacestodes. Parasitol Res. 2009;105(3):835–42.CrossRef
19.
go back to reference Rinaldi F, De Silvestri A, Tamarozzi F, Cattaneo F, Lissandrin R, Brunetti E. Medical treatment versus watch and wait in the clinical management of CE3b cystic echinococcosisof the liver. BMC Infect Dis. 2014;14(1):492.CrossRef Rinaldi F, De Silvestri A, Tamarozzi F, Cattaneo F, Lissandrin R, Brunetti E. Medical treatment versus watch and wait in the clinical management of CE3b cystic echinococcosisof the liver. BMC Infect Dis. 2014;14(1):492.CrossRef
Metadata
Title
Viability predictive factors of the daughter vesicles in hepatic cystic echinococcosis
Authors
Aymen Trigui
Nahed Khmekhem
Sami Fendri
Rahma Daoud
Amira Akrout
Jihene Trabelsi
Rafik Mzali
Fatma Cheikhrouhou
Ali Ayadi
Chadli Dziri
Mohamed Ben Amar
Saleh Boujelbene
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Echinococcosis
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08937-y

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine